What is the global market size of Single Use Bioprocessing Market?

Single Use Bioprocessing Market size was valued at USD 13.50 billion in 2022 and is poised to grow from USD 15.46 billion in 2023 to USD 45.67 billion by 2031, growing at a CAGR of 14.5% in the forecast period (2024-2031).

Who are the key vendors in the Global Single Use Bioprocessing Market?

The global single use bioprocessing market is moderately competitive with the presence of many international and regional market players operating all over the world. The top 5 companies of the market dominated the majority of market share including Thermo Fisher Scientific, Sartorius AG, and Eppendorf AG. Key players are implementing on several business strategies including new innovation, acquisition, mergers, partnerships, and collaboration for the expansion of their geographical presence and product portfolio. 'Thermo Fisher Scientific, Inc.', 'Sartorius AG', 'Merck KGaA', 'GE Healthcare Life Sciences', 'Pall Corporation (a Danaher Company)', 'Parker Hannifin Corporation', 'Eppendorf AG', '3M Company', 'Meissner Filtration Products, Inc.', 'Entegris, Inc.', 'Repligen Corporation', 'Saint-Gobain Performance Plastics Corporation', 'Finesse Solutions, Inc. (a part of Thermo Fisher Scientific, Inc.)', 'ATMI LifeSciences (a part of Entegris, Inc.)', 'Applikon Biotechnology BV', 'PendoTECH', 'Corning, Inc.', 'Cesco Bioengineering Co., Ltd.', 'Fujifilm Irvine Scientific', 'Abec, Inc.'

Single Use Bioprocessing Market Size

Single Use Bioprocessing Market Insights

Single Use Bioprocessing Market size was valued at USD 15.46 Billion in 2023 and is poised to grow from USD 17.7 Billion in 2024 to USD 52.29 Billion by 2032, growing at a CAGR of 14.5% during the forecast period (2025-2032).

Increasing popularity of single use technology due to the reduction in capital cost and facility construction time coupled with the rising prevalence of disposables in the bioprocessing industry are the major factors expected to drive the global single use bioprocessing market over the forecast period. In addition, rising adoption of disposables among various manufacturing organizations and increasing number of innovations of new and advanced devices are also projected to contribute significantly to the growth of the market. For instance, in May 2022, ILC Dover LP announced the launch of its liquid single-use bioprocessing bags for supplying sterile liquids. It will help the company to expand its product offerings in the single use bioprocessing global market.

Furthermore, an extensive growing number of vendors and suppliers offering robust disposables and other types of biopharmaceutical commercials is another key factor likely to boost the growth and demand for single use bioprocessing market over the forecast period. Moreover, introduction of innovative and new automation in the bioprocessing industry couple with the development of big data analytics is anticipated to have a positive impact on the global market over the coming years.

US Single Use Bioprocessing Market is poised to grow at a sustainable CAGR for the next forecast year.

FAQs

The global single use bioprocessing market is moderately competitive with the presence of many international and regional market players operating all over the world. The top 5 companies of the market dominated the majority of market share including Thermo Fisher Scientific, Sartorius AG, and Eppendorf AG. Key players are implementing on several business strategies including new innovation, acquisition, mergers, partnerships, and collaboration for the expansion of their geographical presence and product portfolio. 'Sartorius AG ', 'Thermo Fisher Scientific ', 'Danaher Corporation (Cytiva) ', 'Eppendorf AG ', 'Merck KGaA ', '3M ', 'PBS Biotech Inc. ', 'CESCO Bioengineering Co. Ltd ', 'ABEC Inc. ', 'Celltainer Biotech BV ', 'Distek, Inc. ', 'OmniBRx Biotechnologies ', 'Boehringer Ingelheim ', 'Kuhner Shaker AG ', 'Avantor, Inc. ', 'Corning Incorporated ', 'Flexbiosys Inc. ', 'Parker Hannifin Corporation ', 'Meissner Filtration Products ', 'Repligen Corporation '

The growing global aging population is expected to drive the global single use bioprocessing market during the forecast period. According to a report by UN ageing population highlights, approximately 727 million people in the global population were aged 65 and over in 2020, with the figure expected to rise to nearly 1.5 billion by 2050. With the significant increase in the number of elderly people, the demand for biopharmaceuticals is expected to rise significantly, as is the increasing focus and preference of major corporations on the improvement of efficiency and cost reduction of single-use systems.

Increasing number of innovations coupled with the rising prevalence of advanced technology and rapid investing in research & development are likely to create lucrative opportunities for the global single use bioprocessing market in the coming years. Furthermore, rising number of company activities in developing single use disposable systems is also contributing to the growth and demand for the market. For instance, in March 2021, Thermo Fisher Scientific launched its new 3,000 L and 5,000 L HyPerforma single use bioreactors.

Globally, North America dominated the single use bioprocessing market and accounted for a healthy market share in 2021 and is expected to maintain its dominance throughout the forecast period. The rising biopharmaceutical research & development activities and large presence of international market players such as Thermo Fisher Scientific Inc., Danaher Corporation, and G&G Technologies in the region are the major factors projected to drive the growth of the market over the coming years. For instance, in January 2021, Fujifilm Diosynth invested an amount of USD 2 billion in its United States sites for the expansion of its cell culture production in the country.